Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chison Medical Technologies CoSHSE:688358 -8.80%85 EBITDA Margin % is 39.43% as of Mar. 2026, which is 19% above its 10-year median of 33.11. GuruFocus rates SHSE:688358 with a GF Score™ of 85/100 and a GF Value™ of ¥33.87 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Chison Medical Technologies Co ranks better than 90.93% on this metric.
Chison Medical Technologies Co (SHSE:688358) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Chison Medical Technologies Co EBITDA Margin % Related Terms
Chison Medical Technologies Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chison Medical Technologies Co EBITDA Margin % Chart
SHSE:688358 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Chison Medical Technologies Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chison Medical Technologies Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chison Medical Technologies Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Chison Medical Technologies Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chison Medical Technologies Co (SHSE:688358) has a EBITDA Margin % of 39.43% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chison Medical Technologies Co and its competitors. This is 19% above median its historical median of 33.11. Over the past decade, Chison Medical Technologies Co's EBITDA Margin % has ranged from 17.67 to 36.70. According to the industry distribution chart, Chison Medical Technologies Co ranks #74 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 9.1%.
Is Chison Medical Technologies Co's EBITDA Margin % too high?
Chison Medical Technologies Co's current EBITDA Margin % of 39.43% is 19% above median its 10-year median of 33.11. Over the past 10 years, this metric has ranged from a low of 17.67 to a high of 36.70. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Chison Medical Technologies Co's value of 39.43% is 427.5% above this industry median. Based on the distribution chart, Chison Medical Technologies Co ranks #74 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Chison Medical Technologies Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chison Medical Technologies Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Chison Medical Technologies Co ranks #74 out of 816 companies for EBITDA Margin %. This places Chison Medical Technologies Co in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Chison Medical Technologies Co's value of 39.43% is 427.5% above this benchmark. Historically, Chison Medical Technologies Co's own EBITDA Margin % has ranged from 17.67 to 36.70 over the past decade. While the company's 10-year median is 33.11 vs. the industry median of 7.48, Chison Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chison Medical Technologies Co's current EBITDA Margin % of 39.43% is 427.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Chison Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chison Medical Technologies Co's current EBITDA Margin % is 39.43%, which is 19% above median its own 10-year median of 33.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chison Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Chison Medical Technologies Co (SHSE:688358) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥33.87, compared to a current price of ¥28.80 — trading 15% below its estimated fair value. The current EBITDA Margin % is 39.43%, which is 19% above median its 10-year median of 33.11 and 427.5% above the Medical Devices & Instruments industry median of 7.48. Chison Medical Technologies Co's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Chison Medical Technologies Co (SHSE:688358), the current EBITDA Margin % is 39.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chison Medical Technologies Co (SHSE:688358) Overvalued in 2026?
Based on GuruFocus' analysis, Chison Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥28.80 is trading 15% below its estimated GF Value™ of ¥33.87.
GuruFocus considers Chison Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SHSE:688358:
EBITDA Margin %: 39.43% (19% above median its 10-year median of 33.11)
GF Value™: ¥33.87 vs. price of ¥28.80 (15% below fair value)
Industry Position: 427.5% above the Medical Devices & Instruments median (#74 of 816)
No single metric tells the full story. See the SHSE:688358 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chison Medical Technologies Co Business Description
Chison Medical Technologies Co Ltd is a manufacturer and seller of ultrasound medical imaging equipment. The company provides ultrasound diagnostic equipment, health equipment, instrumentation, electronic components, electronic products, electronic equipment, trolleys, general equipment and accessories. Its products include Color Doppler, and B/W system.
85GF Score
Get the complete analysis for SHSE:688358
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688358 has been successfully added to your 
